A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia

Completed · Phase 1/Phase 2 · Has a placebo group

Conditions studied: Presbyopia

In brief

The purpose of this study is to determine whether EV06 Ophthalmic Solution is safe and effective in improving distance corrected near vision in people who have presbyopia.

Key facts

Study ID

NCT02516306

Run by

Encore Vision, Inc.

People needed

75

Starts

2015-09-16

Expected to finish

2016-03-10

Last updated by the study team

2018-07-02

Who can join

Age: 45 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 45 to 55 years of age
• Distance Corrected Near Visual Acuity worse than 20/40
• Best Corrected Distance Visual Acuity of 20/20 or better in each eye
• Willing and able to sign consent, following study instructions

You may not qualify if…

• Certain pupillary conditions
• Significant astigmatism, glaucoma, diabetes, cataracts, eye surgery, ocular trauma or accommodative issues
• contact lens wear within 3 days prior to and for duration of study
• use of prohibited medications
• participation in a clinical study within 30 days prior

Where it is running

• Sall Research Medical Center, Inc. — Artesia, California, United States
• North Valley Eye Medical Group — Mission Hills, California, United States
• Comprehensive Eye Care, Ltd. — Washington, Missouri, United States
• Total Eye Care — Memphis, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.